Dr. Mark Delworth on Robotic Prostatectomy

Mark Delworth, MD
Published: Monday, Feb 09, 2015



Mark Delworth, MD, a urologist and the medical director of the Minimally Invasive and Robotic Surgery Program at TriHealth Hospital, talks about the outcomes of robotic surgery for the treatment of prostate cancer.

The biggest advantages of robotic prostatectomy are less pain and blood loss and shorter hospitalization and recovery time, says Delworth. Some studies have also shown that robotic surgeries improve pathological parameters, leading to a reduction in recurrence rates. However not every study has confirmed these findings.

There is also some question as to if robotic prostatectomies result in the same functional status outcomes as traditional surgeries, including sexual function and urinary control. Delworth feels that studies support that robotic surgery actually delivers better functional status outcomes.



Mark Delworth, MD, a urologist and the medical director of the Minimally Invasive and Robotic Surgery Program at TriHealth Hospital, talks about the outcomes of robotic surgery for the treatment of prostate cancer.

The biggest advantages of robotic prostatectomy are less pain and blood loss and shorter hospitalization and recovery time, says Delworth. Some studies have also shown that robotic surgeries improve pathological parameters, leading to a reduction in recurrence rates. However not every study has confirmed these findings.

There is also some question as to if robotic prostatectomies result in the same functional status outcomes as traditional surgeries, including sexual function and urinary control. Delworth feels that studies support that robotic surgery actually delivers better functional status outcomes.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x